Unlisted
| Company Name | (주)비씨월드제약 |
| English Name | BCWORLDPHARM Co., Ltd. |
| Business Reg. No. | 1398111269 |
| CEO | 홍성한 |
| Address | 경기도 여주시 가남읍 여주남로 872-23 |
| Industry | 합성의약품 및 기타 완제 의약품 제조업 |
| Industry Code | 212 |
| Established | 19800319 |
| Phone | 031-881-6800 |
| Website | www.bcwp.co.kr |
| Regular Employees | 280persons |
| Corp. Reg. No. | 1243110005515 |
Venture Certified
| 연구개발기업 | 2000-07-27 ~ 2002-07-26 | 20001727210650 | 2000-07-27 |
| 연구개발기업 | 2002-11-15 ~ 2004-11-14 | 021722021301270 | 2000-07-27 |
| 연구개발기업 | 2002-11-15 ~ 2004-11-14 | 021722021-03-1270 | 2000-07-27 |
| 연구개발기업 | 2004-11-15 ~ 2006-11-14 | 041722021400127 | 2000-07-27 |
| 기술평가보증기업(기금) | 2006-11-15 ~ 2007-11-14 | 20060100723 | 2000-07-27 |
| 기술평가보증기업(기금) | 2007-11-15 ~ 2008-11-14 | 20070104115 | 2000-07-27 |
| 연구개발유형 | 2009-03-19 ~ 2011-03-18 | 20090400169 | 2000-07-27 |
| 연구개발유형 | 2011-08-03 ~ 2013-08-02 | 20110400439 | 2000-07-27 |
| 연구개발유형 | 2013-08-03 ~ 2015-08-02 | 20130400752 | 2000-07-27 |
| 연구개발유형 | 2015-08-03 ~ 2017-08-02 | 20150401063 | 2000-07-27 |
| 연구개발유형 | 2017-08-03 ~ 2019-08-02 | 20170401406 | 2000-07-27 |
| 연구개발유형 | 2019-08-03 ~ 2021-08-02 | 20190401765 | 2000-07-27 |
| 연구개발유형 | 2021-08-03 ~ 2024-08-02 | 20210729020035 | 2000-07-27 |
| 연구개발유형 | 2024-08-03 ~ 2027-08-02 | 20240828020012 | 2000-07-27 |
Revenue CAGR +6.4%
| Item | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 748B | 751B | 727B | 621B |
| Operating Profit | 15B | 64B | 19B | -18B |
| Net Profit | -33B | 29B | 0.6B | -22B |
| Total Assets | 1,763B | 1,841B | 1,831B | 1,851B |
| Total Liabilities | 1,003B | 1,042B | 1,055B | 1,042B |
| Total Equity | 760B | 799B | 775B | 809B |
▲ 6.9%
▼ 30.0%
▼ 26.1%
▲ 0.1%
▼ 1524.3%
| Name | Position | Role | Comp. (M KRW) |
|---|---|---|---|
| 홍성한 | 사내이사 | 총괄경영 | - |
| 이승철 | 사내이사 | 생산자문 | - |
| 홍영기 | 사내이사 | 경영전략 | - |
| 지성규 | 사외이사 | 사외이사 | - |
| 양병국 | 사외이사 | 사외이사 | - |
| 최성남 | 사외이사 | 사외이사 | - |
| Shareholder | Ownership (%) | Shares Held |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - |
| NPS Subscribers | 280persons |
| CEO | 홍성한 |
| Est. Avg. Annual Salary | 4,20410K (35010K/mo) |
| Hired (12 mo) | +14persons |
| Left (12 mo) | -8persons |
| Net Change (12 mo) | +6persons |
| NPS Join Date | 1991-02-11 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
2 Additional Data Sources
{
"address": "경기도 여주시",
"ceo_name": "홍성한",
"certificate": [
{
"cert_number": "20001727210650",
"changes": "",
"disclosure_date": "2000-07-27",
"first_cert_date": "2000-07-27",
"no": "1",
"type": "연구개발기업",
"valid_period": "2000-07-27 ~ 2002-07-26"
},
{
"cert_number": "021722021301270",
"changes": "",
"disclosure_date": "2002-11-15",
"first_cert_date": "2000-07-27",
"no": "2",
"type": "연구개발기업",
"valid_period": "2002-11-15 ~ 2004-11-14"
},
{
"cert_number": "021722021-03-1270",
"changes": "",
"disclosure_date": "2002-11-15",
"first_cert_date": "2000-07-27",
"no": "3",
"type": "연구개발기업",
"valid_period": "2002-11-15 ~ 2004-11-14"
},
{
"cert_number": "041722021400127",
"changes": "",
"disclosure_date": "2004-11-15",
"first_cert_date": "2000-07-27",
"no": "4",
"type": "연구개발기업",
"valid_period": "2004-11-15 ~ 2006-11-14"
},
{
"cert_number": "20060100723",
"changes": "",
"disclosure_date": "2006-12-06",
"first_cert_date": "2000-07-27",
"no": "5",
"type": "기술평가보증기업(기금)",
"valid_period": "2006-11-15 ~ 2007-11-14"
},
{
"cert_number": "20070104115",
"changes": "",
"disclosure_date": "2007-11-20",
"first_cert_date": "2000-07-27",
"no": "6",
"type": "기술평가보증기업(기금)",
"valid_period": "2007-11-15 ~ 2008-11-14"
},
{
"cert_number": "20090400169",
"changes": "",
"disclosure_date": "2009-03-19",
"first_cert_date": "2000-07-27",
"no": "7",
"type": "연구개발유형",
"valid_period": "2009-03-19 ~ 2011-03-18"
},
{
"cert_number": "20110400439",
"changes": "",
"disclosure_date": "2011-08-03",
"first_cert_date": "2000-07-27",
"no": "8",
"type": "연구개발유형",
"valid_period": "2011-08-03 ~ 2013-08-02"
},
{
"cert_number": "20130400752",
"changes": "",
"disclosure_date": "2013-08-09",
"first_cert_date": "2000-07-27",
"no": "9",
"type": "연구개발유형",
"valid_period": "2013-08-03 ~ 2015-08-02"
},
{
"cert_number": "20150401063",
"changes": "",
"disclosure_date": "2015-07-29",
"first_cert_date": "2000-07-27",
"no": "10",
"type": "연구개발유형",
"valid_period": "2015-08-03 ~ 2017-08-02"
},
{
"cert_number": "20170401406",
"changes": "",
"disclosure_date": "2017-07-23",
"first_cert_date": "2000-07-27",
"no": "11",
"type": "연구개발유형",
"valid_period": "2017-08-03 ~ 2019-08-02"
},
{
"cert_number": "20190401765",
"changes": "",
"disclosure_date": "2019-08-02",
"first_cert_date": "2000-07-27",
"no": "12",
"type": "연구개발유형",
"valid_period": "2019-08-03 ~ 2021-08-02"
},
{
"cert_number": "20210729020035",
"changes": "",
"disclosure_date": "2021-07-29",
"first_cert_date": "2000-07-27",
"no": "13",
"type": "연구개발유형",
"valid_period": "2021-08-03 ~ 2024-08-02"
},
{
"cert_number": "20240828020012",
"changes": "",
"disclosure_date": "2024-08-28",
"first_cert_date": "2000-07-27",
"no": "14",
"type": "연구개발유형",
"valid_period": "2024-08-03 ~ 2027-08-02"
}
],
"company_name": "㈜비씨월드제약",
"financials": {
"2022": {
"capital_stock": 1778477000,
"cost_of_sales": 43002542000,
"current_assets": 38422575000,
"current_liabilities": 48869154000,
"gross_profit": 24359103000,
"net_income": -894880000,
"net_income_bs": 437189000,
"non_current_assets": 112782420000,
"non_current_liabilities": 20817477000,
"non_operating_expenses": 3076942000,
"non_operating_income": 968566000,
"operating_profit": 1213496000,
"revenue": 67361645000,
"sga_expenses": 23145607000,
"total_assets": 151204996000,
"total_equity": 81518365000,
"total_liabilities": 69686631000
},
"2023": {
"capital_stock": 1778477000,
"cost_of_sales": 41158353000,
"current_assets": 44488703000,
"current_liabilities": 59919061000,
"gross_profit": 27355261000,
"net_income": 127793000,
"net_income_bs": 2361863000,
"non_current_assets": 110705966000,
"non_current_liabilities": 11938112000,
"non_operating_expenses": 3740923000,
"non_operating_income": 661875000,
"operating_profit": 3206841000,
"revenue": 68513614000,
"sga_expenses": 24148420000,
"total_assets": 155194669000,
"total_equity": 83337497000,
"total_liabilities": 71857172000
}
},
"industry": "합성의약품 및 기타 완제 의약품 제조업",
"investment": [],
"phone": "031-881-****",
"source": "pg_migration"
}{
"address": "경기도 여주시 가남읍 여주남로",
"brno": "139811****",
"cappedWarning": false,
"companyName": "(주)비씨월드제약",
"estimatedAvgAnnualSalary": 42043140,
"estimatedAvgMonthlySalary": 3503595,
"fetchedAt": "2026-03-05T13:39:56.437Z",
"industryCode": "242301",
"industryName": "완제 의약품 제조업",
"joinDate": "19910211",
"last12MonthsHired": 14,
"last12MonthsLeft": 8,
"last12MonthsNetChange": 6,
"leaveDate": null,
"monthlyPensionAmount": 93195620,
"monthlyTrend": [
{
"lostSubscribers": 8,
"newSubscribers": 14,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6675989",
"status": "1",
"styleCode": "1",
"subscriberCount": 280,
"turnoverMonths": 1
}Data Quality: 95/10 | Primary Source: Venture System | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | DART | Collected |
| Investment Metrics | DART | Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| Venture System Detail | 2026-03-05 | Collected |
| SME Status Info | 2026-03-05 | Collected |
| nps | 2026-03-05 | Collected |
| DART Financial | 2026-02-27 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |